You are here

Article info

Article menu
Download PDFPDF
2. Adaptive immunity
A2.35 Glatiramer acetate restores the defective activity of regulatory B cells in SLE

Authors

  • K Amrouche INSERM ERI29, EA2216, Immunology and Pathology, Université de Brest and the Université Européenne de Bretagne, Labex IGO, Immunotherapy, Graft, Oncology, CHRU de Brest, Brest, France PubMed articlesGoogle scholar articles
  • JO Pers INSERM ERI29, EA2216, Immunology and Pathology, Université de Brest and the Université Européenne de Bretagne, Labex IGO, Immunotherapy, Graft, Oncology, CHRU de Brest, Brest, France PubMed articlesGoogle scholar articles
  • S Hillion INSERM ERI29, EA2216, Immunology and Pathology, Université de Brest and the Université Européenne de Bretagne, Labex IGO, Immunotherapy, Graft, Oncology, CHRU de Brest, Brest, France PubMed articlesGoogle scholar articles
  • C Jamin INSERM ERI29, EA2216, Immunology and Pathology, Université de Brest and the Université Européenne de Bretagne, Labex IGO, Immunotherapy, Graft, Oncology, CHRU de Brest, Brest, France PubMed articlesGoogle scholar articles

Citation

Amrouche K, Pers J, Hillion S, et al
A2.35 Glatiramer acetate restores the defective activity of regulatory B cells in SLE
Annals of the Rheumatic Diseases 2016;75:A29.

Publication history

  • First published February 24, 2016.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions